Nodular regenerative hyperplasia in patients with inflammatory bowel disease treated with azathioprine

Gut

Volumn 56, Issue 10, 2007, Pages 1404-1409

  Vernier Massouille, Gwenola ^b   Cosnes, Jacques ^c   Lemann, Marc ^d   Marteau, Philippe ^e   Reinisch, Walter ^f   Laharie, David ^g   Cadiot, Guillaume ^h   Bouhnik, Yoram ⁱ   De Vos, Martine ^j   Boureille, Arnaud ^k   Duclos, Bernard ^l   Seksik, Philippe ^c   Mary, Jean Yves ^m   Colombel, Jean Frédéric ^a,b  

^a UNIV LILLE   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

^c HÔPITAL SAINT ANTOINE   (France)

^d SAINT LOUIS HOSPITAL   (France)

^e HÔPITAL LARIBOISIÈRE   (France)

^f UNIVERSITY OF VIENNA   (Austria)

^g HAUT LÉVÊQUE HOSPITAL   (France)

^h SERVICE DE DERMATOLOGIE   (France)

ⁱ BEAUJON HOSPITAL   (France)

^j GHENT UNIVERSITY   (Belgium)

^k HÔTEL DIEU   (France)

^l HÔPITAL DE HAUTEPIERRE   (France)

^m INSERM   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE;

ADULT; AGED; ARTICLE; AWARENESS; CALCULATION; CASE CONTROL STUDY; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL FEATURE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA BASE; DISEASE COURSE; ENTERITIS; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; HYPERPLASIA; LIVER FUNCTION TEST; MALE; MONITORING; MORBIDITY; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; NODULAR HYPERPLASIA; NODULAR REGENERATIVE HYPERPLASIA; PHYSICIAN; PORTAL HYPERTENSION; PRIORITY JOURNAL; RISK; RISK FACTOR; SEX; THROMBOCYTE COUNT; TIME;

EID: 34948824782     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2006.114363     Document Type: Article

References (35)

1. Steiner PE. Nodular regenerative hyperplasia of the liver. Am J Pathol 1959;35:943-53.
2. Stromeyer FW, Ishak KG. Nodular transformation (nodular "regenerative" hyperplasia) of the liver. A clinicopathologic study of 30 cases. Hum Pathol 1981;12:60-71.
3. Arvanitaki M, Adler M. Nodular regenerative hyperplasia of the liver. A review of 14 cases. Hepatogastroenterology 2001;48:1425- 9.
4. Wanless IR, Godwin TA, Allen F, et al. Nodular regenerative hyperplasia of the liver in hematologic disorders: a possible response to obliterative portal venopathy. A morphometric study of nine cases with an hypothesis on the pathogenesis. Medicine 1980;59:367-79.
5. Naber AH, Van Haelst U, Yap SH. Nodular regenerative hyperplasia of the liver: an important cause of portal hypertension in non-cirrhotic patients. J Hepatol 1991;12:94-9.
6. Buffet C, Cantarovitch M, Pelletier G, et al. Three cases of nodular regenerative hyperplasia of the liver following renal transplantation. Nephrol Dial Transplant 1988;3:327-30.
7. Haboubi NY, Ali HH, Whitwell HL, et al. Role of endothelial cell injury in the spectrum of azathioprine-induced liver disease after renal transplant: light microscopy and ultrastructural observations. Am J Gastroenterol 1988;83:256-61.
8. Jones MC, Best PV, Catto GR. Is nodular regenerative hyperplasia of the liver associated with azathioprine therapy after renal transplantation? Nephrol Dial Transplant 1988;3:331-3.
9. Duvoux C, Kracht M, Lang P, et al. [Nodular regenerative hyperplasia of the liver associated with azathioprine therapy. ] Gastroenterol Clin Biol, 1991;15:968-73.
10. Bredfeldt JE, Havey AL. Nodular regenerative hyperplasia of the liver following renal transplantation. Dig Dis Sci 1981;26:271-4.
11. Katzka DA, Saul SH, Jorkasky D, et al. Azathioprine and hepatic venocclusive disease in renal transplant patients. Gastroenterology 1986;90:446-54.
12. Morales JM, Prieto C, Colina F, et al. Nodular regenerative hyperplasia of the liver in renal transplantation. Transplant Proc 1987;19:3694-6.
13. Colina F, Alberti N, Solis JA, et al. Diffuse nodular regenerative hyperplasia of the liver (DNRH). A clinicopathologic study of 24 cases. Liver 1989;9:253-65.
14. Radomski JS, Chojnacki KA, Moritz MJ, et al. Results of liver transplantation for nodular regenerative hyperplasia. Am Surg 2000;66:1067-70.
15. Gisbert JP, Gonzalez-Lama Y, Mate J. Thiopurine-induced liver injury in patients with inflammatory bowel disease: a systematic review. Am J Gastroenterol 2007;27:27.
16. Arnott ID, Ghosh S. Portal hypertension in the presence of minimal liver damage in Crohn's disease on long-term azathioprine: possible endothelial cell injury. Eur J Gastroenterol Hepatol 2000;12:569-73.
17. Russmann S, Zimmermann A, Krahenbuhl S, et al. Veno-occlusive disease, nodular regenerative hyperplasia and hepatocellular carcinoma after azathioprine treatment in a patient with ulcerative colitis. Eur J Gastroenterol Hepatol 2001;13:287-90.
18. Daniel F, Cadranel JF, Seksik P, et al. Azathioprine induced nodular regenerative hyperplasia in IBD patients. Gastroenterol Clin Biol 2005;29:600-3.
19. Seiderer J, Zech CJ, Diebold J, et al. Nodular regenerative hyperplasia: a reversible entity associated with azathioprine therapy. Eur J Gastroenterol Hepatol 2006;18:553-5.
20. Dubinsky MC, Vasiliauskas EA, Singh H, et al. 6-thioguanine can cause serious liver injury in inflammatory bowel disease patients. Gastroenterology 2003;125:298-303.
21. Satsangi J, Silverberg MS, Vermeire S, et al. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 2006;55:749-53.
22. Cosnes J, Nion-Larmurier I, Beaugerie L, et al. Impact of the increasing use of immunosuppressants in Crohn's disease on the need for intestinal surgery. Gut 2005;54:237-41.
23. Wanless IR, Peterson P, Das A, et al. Hepatic vascular disease and portal hypertension in polycythemia vera and agnogenic myeloid metaplasia: a clinicopathological study of 145 patients examined at autopsy. Hepatology 1990;12:1166-74.
24. Nakanuma Y, Hoso M, Sasaki M, et al. Histopathology of the liver in non-cirrhotic portal hypertension of unknown aetiology. Histopathology 1996;28:195-204.
25. Blanc JF, Bernard PH, Le Bail B, et al. [Vascular pathology of the portal vein distal branches: a rare cause of liver transplantation and a protean clinical presentation. ] Gastroenterol Clin Biol, 2000;24:667-70.
26. Elariny HA, Mizrahi SS, Hayes DH, et al. Nodular regenerative hyperplasia: a controversial indication for orthotopic liver transplantation. Transpl Int 1994;7:309-13.
27. Nzeako UC, Goodman ZD, Ishak KG. Hepatocellular carcinoma and nodular regenerative hyperplasia: possible pathogenetic relationship. Am J Gastroenterol 1996;91:879-84.
28. Snover DC. Thoughts on the development of hepatocellular carcinoma in cirrhotic and noncirrhotic livers. Am J Clin Pathol 1996;105:3-5.
29. Stoneham S, Lennard L, Coen P, et al. Veno-occlusive disease in patients receiving thiopurines during maintenance therapy for childhood acute lymphoblastic leukaemia. Br J Haematol 2003;123:100-2.
30. Dubinski MC. Azathioprine, 6-mercaptopurine in inflammatory bowel disease: pharmacology, efficacy, and safety. Clin Gastroenterol Hepatol 2004;2:731-43.
31. Wanless IR. Micronodular transformation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2,500 autopsies and a new classification of benign hepatocellular nodules. Hepatology 1990;11:787-97.
32. DeLeve LD, Wang X, Kuhlenkamp JF, et al. Toxicity of azathioprine and monocrotaline in murine sinusoidal endothelial cells and hepatocytes: the role of glutathione and relevance to hepatic venoocclusive disease. Hepatology 1996;23:589-99.
33. Buchel O, Roskams T, Van Damme B, et al. Nodular regenerative hyperplasia, portal vein thrombosis, and avascular hip necrosis due to hyperhomocysteinaemia. Gut 2005;54:1021-3.
34. De Boer NK, Mulder Q, Van Bodegraven AA. Nodular regenerative hyperplasia and thiopurines: the case for level-dependent toxicity. Liver Transpl 2005;11:1300-1.
35. Seiderer J, Zech CJ, Reinisch W, et al. A multicenter assessment of liver toxicity by MRI and biopsy in IBD patients on 6-thioguanine. J Hepatol 2005;43:303-9.